Skip to Main Content

Paper Details

Baseline neutrophil-lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use.
Ann Oncol
160
2015
Author NameAffiliation
Joaquin MateoThe Royal Marsden NHS Foundation Trust and The Institute of Cancer Research
Zafeiris ZafeiriouThe Royal Marsden NHS Foundation Trust and The Institute of Cancer Research
Roberta FerraldeschiThe Royal Marsden NHS Foundation Trust and The Institute of Cancer Research
Amit Bahl
Oliver SartorTulane University
Johann S de BonoThe Royal Marsden NHS Foundation Trust and The Institute of Cancer Research
  • 1 - 6

Datasets

Release 1.2